Fetal Sex-Based Differences in Maternal Hormones, Angiogenic Factors, and Immune Mediators During Pregnancy and the Postpartum Period

American Journal of Reproductive Immunology

Volumn 73, Issue 3, 2015, Pages 251-262

  Enninga, Elizabeth Ann L ^a   Nevala, Wendy K ^b   Creedon, Douglas J ^a   Markovic, Svetomir N ^a,b   Holtan, Shernan G ^c  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Angiogenesis; Fetal sex; Immunology; Inflammation; Longitudinal; Pregnancy

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN; CYTOKINE; ENDOGLIN; ENDOTHELIN 1; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 25; INTERLEUKIN 27; INTERLEUKIN 28A; INTERLEUKIN 31; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; LYMPHOTOXIN; PLACENTAL GROWTH FACTOR; SEX HORMONE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A; ANGIOGENIC PROTEIN; AUTACOID; HORMONE; INTERLEUKIN DERIVATIVE;

ADULT; ARTICLE; FEMALE; FETUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATORY DISEASE; MALE; MATERNAL PLASMA; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PREGNANCY; PRIMIGRAVIDA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUERPERIUM; SEX DIFFERENCE; ADOLESCENT; BLOOD; COMPARATIVE STUDY; GESTATIONAL AGE; PHYSIOLOGY; PREGNANCY COMPLICATIONS; RISK; SEXUAL DEVELOPMENT; YOUNG ADULT;

ADOLESCENT; ADULT; ANGIOGENIC PROTEINS; FEMALE; FETUS; GESTATIONAL AGE; HORMONES; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKINS; MALE; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS; RISK; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 84922779922     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12303     Document Type: Article

References (63)

1. Ostensen M, Villiger PM: Immunology of pregnancy-pregnancy as a remission inducing agent in rheumatoid arthritis. Transpl Immunol 2002; 9:155-160.
2. Curry AE, Vogel I, Skogstrand K, Drews C, Schendel DE, Flanders WD, Hougaard DM, Thorsen P: Maternal plasma cytokines in early- and mid-gestation of normal human pregnancy and their association with maternal factors. J Reprod Immunol 2008; 77:152-160.
3. Anderson BL, Mendez-Figueroa H, Dahlke JD, Raker C, Hillier SL, Cu-Uvin S: Pregnancy-induced changes in immune protection of the genital tract: defining normal. Am J Obstet Gynecol 2013; 208:321.e321-329.
4. Soldin OP, Mattison DR: Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 2009; 48:143-157.
5. Pennell LM, Galligan CL, Fish EN: Sex affects immunity. J Autoimmun 2012; 38:J282-291.
6. Zeitlin J, Saurel-Cubizolles MJ, De Mouzon J, Rivera L, Ancel PY, Blondel B, Kaminski M: Fetal sex and preterm birth: are males at greater risk? Hum Reprod 2002; 17:2762-2768.
7. Di Renzo GC, Rosati A, Sarti RD, Cruciani L, Cutuli AM: Does fetal sex affect pregnancy outcome? Gend Med 2007; 4:19-30.
8. Stark MJ, Dierkx L, Clifton VL, Wright IM: Alterations in the maternal peripheral microvascular response in pregnancies complicated by preeclampsia and the impact of fetal sex. J Soc Gynecol Investig 2006; 13:573-578.
9. Shiozaki A, Matsuda Y, Satoh S, Saito S: Impact of fetal sex in pregnancy-induced hypertension and preeclampsia in Japan. J Reprod Immunol 2011; 89:133-139.
10. Clifton V: Maternal asthma during pregnancy and fetal outcomes: potential mechanisms and possible solutions. Curr Opin Allergy Clin Immunol 2006; 6:307-311.
11. Mingrone G, Manco M, Mora ME, Guidone C, Iaconelli A, Gniuli D, Leccesi L, Chiellini C, Ghirlanda G: Influence of maternal obesity on insulin sensitivity and secretion in offspring. Diabetes Care 2008; 31:1872-1876.
12. van Abeelen AF, de Rooij SR, Osmond C, Painter RC, Veenendaal MV, Bossuyt PM, Elias SG, Grobbee DE, van der Schouw YT, Barker DJ, Roseboom TJ: The sex-specific effects of famine on the association between placental size and later hypertension. Placenta 2011; 32:694-698.
13. Ghidini A, Salafia CM: Gender differences of placental dysfunction in severe prematurity. BJOG 2005; 112:140-144.
14. Cvitic S, Longtine MS, Hackl H, Wagner K, Nelson MD, Desoye G, Hiden U: The human placental sexome differs between trophoblast epithelium and villous vessel endothelium. PLoS ONE 2013; 8:e79233.
15. Sood R, Zehnder JL, Druzin ML, Brown PO: Gene expression patterns in human placenta. Proc Natl Acad Sci U S A 2006; 103:5478-5483.
16. Scott NM, Hodyl NA, Murphy VE, Osei-Kumah A, Wyper H, Hodgson DM, Smith R, Clifton VL: Placental cytokine expression covaries with maternal asthma severity and fetal sex. J Immunol 2009; 182:1411-1420.
17. Kim-Fine S, Regnault TR, Lee JS, Gimbel SA, Greenspoon JA, Fairbairn J, Summers K, De Vrijer B: Male gender promotes an increased inflammatory response to lipopolysaccharide in umbilical vein blood. J Matern Fetal Neonatal Med 2012; 25:2470-2474.
18. Potter DM, Butterfield LH, Divito SJ, Sander CA, Kirkwood JM: Pitfalls in retrospective analyses of biomarkers: a case study with metastatic melanoma patients. J Immunol Methods 2012; 376:108-112.
19. D'Acquisto F, Maione F, Pederzoli-Ribeil M: From IL-15 to IL-33: the never-ending list of new players in inflammation. Is it time to forget the humble aspirin and move ahead? Biochem Pharmacol 2010; 79:525-534.
20. Germain SJ, Sacks GP, Sooranna SR, Sargent IL, Redman CW: Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 2007; 178:5949-5956.
21. Doganci A, Birkholz J, Gehring S, Puhl AG, Zepp F, Meyer CU: In the presence of IL-21 human cord blood T cells differentiate to IL-10-producing Th1 but not Th17 or Th2 cells. Int Immunol 2013; 25:157-169.
22. Garlanda C, Dinarello CA, Mantovani A: The interleukin-1 family: back to the future. Immunity 2013; 39:1003-1018.
23. Jin LP, Fan DX, Zhang T, Guo PF, Li DJ: The costimulatory signal upregulation is associated with Th1 bias at the maternal-fetal interface in human miscarriage. Am J Reprod Immunol 2011; 66:270-278.
24. Galvao AM, Ferreira-Dias G, Skarzynski DJ: Cytokines and angiogenesis in the corpus luteum. Mediators Inflamm 2013; 2013:420186.
25. Yano K, Okada Y, Beldi G, Shih SC, Bodyak N, Okada H, Kang PM, Luscinskas W, Robson SC, Carmeliet P, Karumanchi SA, Aird WC: Elevated levels of placental growth factor represent an adaptive host response in sepsis. J Exp Med 2008; 205:2623-2631.
26. Patrelli TS, Gizzo S, Plebani M, Basso D, Capobianco G, Bartolucci C, Modena AB, Rondinelli M, Nardelli GB: The trend of VEGF-A and PlGF in pregnant patients: a perspective case-control study on 214 women. Clin Exp Obstet Gynecol 2012; 39:57-64.
27. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA: Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350:672-683.
28. Scharpfenecker M, van Dinther M, Liu Z, van Bezooijen RL, Zhao Q, Pukac L, Lowik CW, ten Dijke P: BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci 2007; 120:964-972.
29. Cunha SI, Pardali E, Thorikay M, Anderberg C, Hawinkels L, Goumans MJ, Seehra J, Heldin CH, ten Dijke P, Pietras K: Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis. J Exp Med 2010; 207:85-100.
30. Lessey BA, Gui Y, Apparao KB, Young SL, Mulholland J: Regulated expression of heparin-binding EGF-like growth factor (HB-EGF) in the human endometrium: a potential paracrine role during implantation. Mol Reprod Dev 2002; 62:446-455.
31. Wolf HK, Zarnegar R, Oliver L, Michalopoulos GK: Hepatocyte growth factor in human placenta and trophoblastic disease. Am J Pathol 1991; 138:1035-1043.
32. Uehara Y, Minowa O, Mori C, Shiota K, Kuno J, Noda T, Kitamura N: Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 1995; 373:702-705.
33. Barlow JL, McKenzie AN: IL-25: a key requirement for the regulation of type-2 immunity. BioFactors 2009; 35:178-182.
34. Robertson SA, Mau VJ, Young IG, Matthaei KI: Uterine eosinophils and reproductive performance in interleukin 5-deficient mice. J Reprod Fertil 2000; 120:423-432.
35. Schmitt E, Van Brandwijk R, Van Snick J, Siebold B, Rude E: TCGF III/P40 is produced by naive murine CD4 + T cells but is not a general T cell growth factor. Eur J Immunol 1989; 19:2167-2170.
36. Elyaman W, Bradshaw EM, Uyttenhove C, Dardalhon V, Awasthi A, Imitola J, Bettelli E, Oukka M, van Snick J, Renauld JC, Kuchroo VK, Khoury SJ: IL-9 induces differentiation of TH17 cells and enhances function of FoxP3 + natural regulatory T cells. Proc Natl Acad Sci U S A 2009; 106:12885-12890.
37. Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, Zhang M, Mineau F, Pelletier JP: IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 1998; 160:3513-3521.
38. Martinez-Garcia EA, Chavez-Robles B, Sanchez-Hernandez PE, Nunez-Atahualpa L, Martin-Maquez BT, Munoz-Gomez A, Gonzalez-Lopez L, Gamez-Nava JI, Salazar-Paramo M, Davalos-Rodriguez I, Petri MH, Zuniga-Tamayo D, Vargas-Ramirez R, Vazquez-Del Mercado M: IL-17 increased in the third trimester in healthy women with term labor. Am J Reprod Immunol 2011; 65:99-103.
39. Nakashima A, Ito M, Yoneda S, Shiozaki A, Hidaka T, Saito S: Circulating and decidual Th17 cell levels in healthy pregnancy. Am J Reprod Immunol 2010; 63:104-109.
40. Yang Z, Grinchuk V, Urban JF Jr, Bohl J, Sun R, Notari L, Yan S, Ramalingam T, Keegan AD, Wynn TA, Shea-Donohue T, Zhao A: Macrophages as IL-25/IL-33-responsive cells play an important role in the induction of type 2 immunity. PLoS ONE 2013; 8:e59441.
41. Saenz SA, Siracusa MC, Perrigoue JG, Spencer SP, Urban JF Jr, Tocker JE, Budelsky AL, Kleinschek MA, Kastelein RA, Kambayashi T, Bhandoola A, Artis D: IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature 2010; 464:1362-1366.
42. Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TK, Bucks C, Kane CM, Fallon PG, Pannell R, Jolin HE, McKenzie AN: Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010; 464:1367-1370.
43. Hermann-Kleiter N, Baier G: NFAT pulls the strings during CD4 + T helper cell effector functions. Blood 2010; 115:2989-2997.
44. Wegmann TG, Lin H, Guilbert L, Mosmann TR: Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14:353-356.
45. Lin H, Mosmann TR, Guilbert L, Tuntipopipat S, Wegmann TG: Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 1993; 151:4562-4573.
46. Krasnow JS, Tollerud DJ, Naus G, DeLoia JA: Endometrial Th2 cytokine expression throughout the menstrual cycle and early pregnancy. Hum Reprod 1996; 11:1747-1754.
47. Polyzou EN, Evangelinakis NE, Pistiki A, Kotsaki A, Siristatidis CS, Chrelias CG, Salamalekis E, Kassanos DP, Giamarellos-Bourboulis EJ: Angiopoietin-2 primes infection-induced preterm delivery. PLoS ONE 2014; 9:e86523.
48. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA: Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12:642-649.
49. Daponte A, Deligeoroglou E, Garas A, Pournaras S, Hadjichristodoulou C, Messinis IE: Activin A and follistatin as biomarkers for ectopic pregnancy and missed abortion. Dis Markers 2013; 35:497-503.
50. Hunter CA: New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 2005; 5:521-531.
51. Colgan J, Rothman P: All in the family: IL-27 suppression of T(H)-17 cells. Nat Immunol 2006; 7:899-901.
52. Takeda A, Hamano S, Yamanaka A, Hanada T, Ishibashi T, Mak TW, Yoshimura A, Yoshida H: Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J Immunol 2003; 170:4886-4890.
53. Kamiya S, Owaki T, Morishima N, Fukai F, Mizuguchi J, Yoshimoto T: An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4 + T cells. J Immunol 2004; 173:3871-3877.
54. Yoshimura T, Takeda A, Hamano S, Miyazaki Y, Kinjyo I, Ishibashi T, Yoshimura A, Yoshida H: Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4 + T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4 + T cells partially through STAT3-dependent mechanism. J Immunol 2006; 177:5377-5385.
55. Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB, Gery I, Lee YS, Egwuagu CE: TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 2007; 13:711-718.
56. Kollman C, Howe CW, Anasetti C, Antin JH, Davies SM, Filipovich AH, Hegland J, Kamani N, Kernan NA, King R, Ratanatharathorn V, Weisdorf D, Confer DL: Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001; 98:43-51.
57. Remberger M, Kumlien G, Aschan J, Barkholt L, Hentschke P, Ljungman P, Mattsson J, Svennilson J, Ringden O: Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2002; 8:674-682.
58. Gratwohl A, Hermans J, Niederwieser D, van Biezen A, van Houwelingen HC, Apperley J: Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants. Hematol J 2001; 2:363-370.
59. Randolph SS, Gooley TA, Warren EH, Appelbaum FR, Riddell SR: Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood 2004; 103:347-352.
60. Gahrton G, Iacobelli S, Apperley J, Bandini G, Bjorkstrand B, Blade J, Boiron JM, Cavo M, Cornelissen J, Corradini P, Kroger N, Ljungman P, Michallet M, Russell NH, Samson D, Schattenberg A, Sirohi B, Verdonck LF, Volin L, Zander A, Niederwieser D: The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants. Bone Marrow Transplant 2005; 35:609-617.
61. -Stern M, Passweg JR, Locasciulli A, Socie G, Schrezenmeier H, Bekassy AN, Fuehrer M, Hows J, Korthof ET, McCann S, Tichelli A, Zoumbos NC, Marsh JC, Bacigalupo A, Gratwohl A: Influence of donor/recipient sex matching on outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia. Transplantation 2006; 82:218-226.
62. Ofran Y, Kim HT, Brusic V, Blake L, Mandrell M, Wu CJ, Sarantopoulos S, Bellucci R, Keskin DB, Soiffer RJ, Antin JH, Ritz J: Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes. Clin Cancer Res 2010; 16:1642-1651.
63. Lin PY, Sun L, Thibodeaux SR, Ludwig SM, Vadlamudi RK, Hurez VJ, Bahar R, Kious MJ, Livi CB, Wall SR, Chen L, Zhang B, Shin T, Curiel TJ: B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responses. J Immunol 2010; 185:2747-2753.